While the Overweight rating suggests that Piper Sandler still sees Accolade as a good investment, the reduction in the price target could imply that there are some concerns about the company's future performance or market conditions that might limit its stock price growth. This news is likely to have a neutral short-term impact on the stock as the positive rating is counterbalanced by the lowered price target.